Search - tctmd.com

Displaying 1 - 20 of 21

Sort: Relevancy | Date

News Conference News TCT 2016

ILLUMENATE: Low-Dose DCB Bests Angioplasty Alone in Complex Patients With SFA/Popliteal Lesions

L.A. McKeown

November 07, 2016

Presentation TCT 2016

Rapid Fire Update: Latest Outcomes From the SFA Randomized Trials I - IN.PACT SFA

Presenter: Koen Deloose, William A. Gray, John R. Laird Jr.

November 01, 2016

Presentation TCT 2016

Trial #9 - The Essentials ofIN.PACT SFA: 3-year Outcomes of a Paclitaxel-Coated Balloon for Femoropopliteal Lesions

Presenter: William A. Gray, Stephan Windecker, John R. Laird Jr.

October 31, 2016

Presentation TCT 2015

IN.PACT SFA: A Prospective Randomized Trial of a Drug-Coated Balloon for Femoropopliteal Lesions - Two-Year Outcomes

Presenter: Cindy L. Grines, John R. Laird Jr

October 14, 2015

News Conference News TCT 2015

IN.PACT SFA: Benefits of DCB Persist at 2 Years

October 14, 2015

Presentation TCT 2015

DCB in BTK Intervention: Summary of the Evidence From 2 Failed RCTs IN.PACT DEEP and BIOLUX P-II

Presenter: Gary M. Ansel, J. A. Mustapha

October 12, 2015

Presentation TCT 2015

The IN.PACT Global Registry: One-Year Outcomes Using the IN.PACT DCB in an Unrestricted, Real-World Environment

Presenter: John R. Laird Jr, Gunnar Tepe, Gary M. Ansel

October 12, 2015

Presentation TCT 2015

IN.PACT SFA 1-year Outcomes: Subgroup Analyses

Presenter: William A. Gray, Peter A. Schneider, John R. Laird Jr

October 12, 2015

Presentation TCT 2015

Review of Multicenter, Randomized Outcomes Data of Antiproliferative Therapies: Zilver PTX, LEVANT II, In.PACT SFA, and DEFINITIVE AR

Presenter: Gary M. Ansel, Michael R. Jaff, Ravish Sachar

October 11, 2015

Presentation TCT 2014

CON: There Is No Proof of Efficacy: IN.PACT DEEP Trumps All!

Presenter: Dierk Scheinert

September 15, 2014

Presentation TCT 2014

PRO: IN.PACT DEEP was Flawed!

Presenter: Francesco Liistro

September 15, 2014

Presentation TCT 2014

TCT 532: Economic Outcomes of Endovascular Femoropopliteal Intervention Using Drug-Coated Balloons vs Standard PTA: 1-Year Results from the IN.PACT SFA II Trial

Presenter: Peter A. Schneider, Gunnar Tepe, Michael H. Wholey, Adam Salisbury, MD

September 15, 2014

Presentation TCT 2014

DCB Use in the Real World III: The IN.PACT Global Registry: First Report of Prospective Outcomes Using the IN.PACT DCB in an Unrestricted, Real-World Environment

Presenter: Kenneth Rosenfield, Thomas Zeller, Raghu Kolluri, Gary M. Ansel

September 15, 2014

Presentation TCT 2014

Randomized Controlled Trials I: New Insights From INPACT SFA II

Presenter: Kenneth Rosenfield, Thomas Zeller, Raghu Kolluri, John R. Laird Jr

September 15, 2014

Presentation TCT 2013

IN.PACT SFA II

Presenter: Peter Schneider

October 31, 2013

Presentation TCT 2013

IN.PACT (Medtronic)

Presenter: Andrej Schmidt

October 31, 2013

News Conference News TCT 2013

Drug-coated Balloons May Become Standard of Care in ISR

October 31, 2013

News Conference News TCT 2012

Paclitaxel-Eluting Balloon Results in High Patency Rate at 1 Year in Below-the-Knee Lesions

October 25, 2012

News Conference News TCT 2012

DEBATE-SFA Favors Predilatation with Drug-Eluting Balloon Before BMS

October 24, 2012

Presentation TCT 2012

Clinical Evaluation of the IN.PACT Drug-eluting Balloon for Treatment of Femoro-popliteal Arterial Disease: Twelve Month Results from a Multicenter Italian Registry

Presenter: Antonio Micari, Angelo Cioppa, Giuseppe Vadal?, Fausto Castriota, Armando Liso, Alfredo Marchese, Alberto Cremonesi, Paolo Rubino, Giancarlo Biamino

January 03, 2012

Advertisement

ILLUMENATE: Low-Dose DCB Bests Angioplasty Alone in Complex Patients With SFA/Popliteal Lesions

Rapid Fire Update: Latest Outcomes From the SFA Randomized Trials I - IN.PACT SFA

Trial #9 - The Essentials ofIN.PACT SFA: 3-year Outcomes of a Paclitaxel-Coated Balloon for Femoropopliteal Lesions

IN.PACT SFA: A Prospective Randomized Trial of a Drug-Coated Balloon for Femoropopliteal Lesions - Two-Year Outcomes

IN.PACT SFA: Benefits of DCB Persist at 2 Years

DCB in BTK Intervention: Summary of the Evidence From 2 Failed RCTs IN.PACT DEEP and BIOLUX P-II

The IN.PACT Global Registry: One-Year Outcomes Using the IN.PACT DCB in an Unrestricted, Real-World Environment

IN.PACT SFA 1-year Outcomes: Subgroup Analyses

Review of Multicenter, Randomized Outcomes Data of Antiproliferative Therapies: Zilver PTX, LEVANT II, In.PACT SFA, and DEFINITIVE AR

CON: There Is No Proof of Efficacy: IN.PACT DEEP Trumps All!

PRO: IN.PACT DEEP was Flawed!

TCT 532: Economic Outcomes of Endovascular Femoropopliteal Intervention Using Drug-Coated Balloons vs Standard PTA: 1-Year Results from the IN.PACT SFA II Trial

DCB Use in the Real World III: The IN.PACT Global Registry: First Report of Prospective Outcomes Using the IN.PACT DCB in an Unrestricted, Real-World Environment

Randomized Controlled Trials I: New Insights From INPACT SFA II

IN.PACT SFA II

IN.PACT (Medtronic)

Drug-coated Balloons May Become Standard of Care in ISR

Paclitaxel-Eluting Balloon Results in High Patency Rate at 1 Year in Below-the-Knee Lesions

DEBATE-SFA Favors Predilatation with Drug-Eluting Balloon Before BMS

Clinical Evaluation of the IN.PACT Drug-eluting Balloon for Treatment of Femoro-popliteal Arterial Disease: Twelve Month Results from a Multicenter Italian Registry

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content